The catalysts over the next few months are probably all
The catalysts over the next few months are probably all being choreographed to fit into AMBS' master plan.
They have put their stake in the ground regarding LymPro Commercialization (December) and up listing. (NASDAQ in November or December). They've also pretty much put their stake in the ground regarding the one billion authorized shares and the diagnostic spin off. Huffman was probably brought on specifically to do this "financial engineering." Gerald's credibility is on the line. He has publicly stated these things in a way he can't back out now.
So we've had a couple days go by without earth shattering news. LOL! How immature shareholders and message board posters can be. (Me especially!) Gerald is moving mountains to transform AMBS and much of the message board conversation is about Gerald's lack of performance and credibility. I can't believe that. I could make a list of all the things I know AMBS is moving forward with that would blow your mind. I've done it before many times, and so have others. Gerald just might be up for the CEO of the Year Award if he pulls off HALF of what I think he is attempting! And, there is a lot he is doing that none of us even know anything about! This is an incredible company and Gerald is a miracle maker!
I am feel very good about what's going on. The last couple of day's lull in news means absolutely nothing! And those like Solantey that are making a big deal about it should be ashamed of themselves and banned immediately from this board!
I think the master plan calls for revenue guidance during the CC on Sept. 2nd. I think releasing the "bridge data" before that makes sense. I think announcing our LymPro partner in the first half of September also makes sense, before the Shareholder meeting on the 22nd. Also, the partner needs 3 months to perform their validation test in their lab. They need to start in mid Sept. to end by mid December. That's a fact!
We're close ladies and gentleman. Relax and let it unfold. Be careful about selling shares too cheaply. I've only been through what we're about to go through once. That stock went from $8 to $81 in 8 months! My only regret is that I sold too early. I started selling off in the high teens and was completely out by $38. When a company like AMBS takes off.....it's a real spectacle! Hang on to your shares.
Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Northwood's Bold Leap into Space Connectivity Here's a nugget of info that could jolt your morning coffee: Northwood Space Corp—yeah, the folks linking satellites to Earth—just pulled in a whopping $375 million in Series C funding. This ain't your average capital injection; it's a full-throttle push to broaden their ground network reach and revamp space...
Continue Reading
When Halloween rolls around, you expect rabid kids clamoring for candy corn and chocolate bars. But this year, Idaho threw a spud into the sweets machine. Idaho's Potatoes Steal the Show In an unexpected twist, the Idaho Potato Commission ran a zany experiment on Halloween: kids had to choose between their beloved Halloween candy and a genuine Idaho potato. Imagine the...
Continue Reading
Keeping the Wireless IP Crown Against All Odds Look, I've seen dominance play out in the markets over the years, but Ceva’s stranglehold on the wireless interface IP market is something fierce. They've got a whopping 68% market share, and folks, that’s 12 times their closest competitor. Talk about leaving the competition eating dust! For a field growing at a solid...
Continue Reading
A Partnership with Serious Implications Here's a fresh duo in the financial frontier—HashKey On-Chain and RD Technologies are teaming up in a bid to push the RDUSD stablecoin into the heart of cross-border trade and finance. And why does it matter? Well, in the wild west of digital finance, stablecoins are the solid ground, and these two are planting their flag. It's a...
Continue Reading
A Bold Move into the U.S. Market MetaOptics Ltd, the semiconductor optics dynamo out of Singapore, is kicking up some investment dust with their American Depositary Receipts (ADR) Programme aimed squarely at expanding its U.S. footprint. And let me tell you, in the game of international market expansion, that's no rookie maneuver. Why ADR? Why Now? So, why is MetaOptics...
Continue Reading
A Swell of Veteran Candidates Hits the Midterm Shores Just when you think you've seen it all in politics, here comes another twist. As the 2026 midterms gear up, an impressive 258 military veterans are throwing their hats into the congressional ring. That's a jump up from 213 just two years back, and let me tell you, it's not just a numbers game—it's a sea change. Women...
Continue Reading
A New Takeoff for Airline B2B Payments Dusting off the cobwebs of traditional payment processes, YeePay has been busy at the 2026 IATA WFS & WPS, held on the glitzy floor of the Galaxy International Convention Center in Macau from October 28 to 29. They're not just chatting about travel; they're rolling out a novel way to tackle the headaches in airline B2B order...
Continue Reading
Diving into Investcorp's Robust 2026 Performance If you're clued into the investment scene, you'll know that a $65.2 billion asset base isn't small potatoes. At the Gateway Gulf 2026, Investcorp didn't just present numbers—they laid out a dramatic year of action packed with billion-dollar dreams. While the dust hasn't quite settled yet, the first nine months of the year...
Continue Reading
The Thrill of Earnings Season Every trader worth their salt gets a tingle down the spine come earnings season. There's nothing quite like it—the build-up, the anticipation, the potential payouts. This time, we're zeroing in on Target Hospitality, bearing the ticker NASDAQ: TH. Come November 9, 2026, they're set to unveil what the past quarter had up its sleeve, and like...
Continue Reading
Bahrain's Bold Moves to Woo Global Investment Bahrain's never been one to tiptoe around, huh? With a whopping USD 3.89 billion on the line, the Kingdom's flashing its neon sign to investors: "Open for Business!" These Golden License projects aren't just a few shiny new ventures — they're bridging aviation logistics, real estate, and the tech sector. Talk about ambition....
Continue Reading
les